Abstract:Mycophenolate mofetil (MMF), the morpholinoethyl ester of mycophenolic acid (MPA), is currently used as an immunosuppressive agent in kidney transplant recipients. After oral administration, MMF is hydrolysed to MPA, the active compound, which is a potent inhibitor of inosine monophosphate dehydrogenase (IMP-DH), Inhibition of this enzyme results in a depletion of the intracellular GTP and dGTP pools. MPA has been shown to inhibit the replication of a number of viruses, including arena viruses (Junin and Tacaribe), yellow fever virus, reovirus-1, parainfluenza-3 virus, Coxsackie B4 virus, Epstein-Barr virus and human immunodeficiency virus. To examine whether MPA also has an inhibitory effect on HBV replication, experiments were performed using cultures of primary human hepatocytes and HBV-transfected, HepG2 2.2.15 cells. After in vitro infection with HBV in human hepatocytes, HBV covalently-closed-circular (ccc) DNA and HBV mRNAs were detectable in the cells during the 10 days following infection, HBV DNA and hepatitis B surface antigen (HBsAg) were also secreted into the culture medium. In the presence of 10 mu g ml(-1) MPA (the therapeutic serum level of MPA as an immunosuppressive agent) in culture medium, HBV ccc DNA and HBV mRNAs became undetectable 5 days after treatment was started. The secretion of HBV DNA and HBsAg into the medium was also markedly reduced, No cytotoxic effect of the drug was noted during the experiments. The effect of MPA on HBV replication was abolished by the presence of guanosine (50 mu g ml(-1)). In HepG2 2.2.15 cells (which contain an integrated tandem dimer of the HBV genome), MPA treatment had no significant inhibitory effect on the secretion of HBV DNA and HBsAg into the culture medium. HBV ccc DNA and HBV mRNAs in HepG2 2.2.15 cells were also not affected. The observed effect of MPA on HBV replication in primary human hepatocyte cultures may involve only episomal replication and may have clinical implications, especially before integration of HBV DNA into the host genome.

Mycophenolic Acid：a Novel Immunosuppressive Drug

Mycophenolic Acid Derivatives With Immunosuppressive Activity From The Coral-Derived Fungus Penicillium Bialowiezense

Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents

Derivatives of mycophenolic acid inhibit T cell-mediated immune function of Balb/c mouse

Synthesis and immunosuppressive activity of some side-chain variants of mycophenolic acid

Polysaccharide Mycophenolate-Based Nanoparticles for Enhanced Immunosuppression and Treatment of Immune-Mediated Inflammatory Diseases

From mice to man: the preclinical history of mycophenolate mofetil

Mizoribine and mycophenolate mofetil

Effects of Mycophenolic Acid on Endothelial Cells.

Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen

Novel action of 3,4-DAA ameliorating acute liver allograft injury.

Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells

Effects of mycophenolate acid and its derivatives on human T-cells and mixed leukocytes

Delineation Of Biological And Molecular Mechanisms Underlying The Diverse Anticancer Activities Of Mycophenolic Acid

Effects of Mycophenolic Acid on IMPDH Activity in Peripheral Blood Mononuclear Cells in Liver Transplant Patients

Progress in Mycophenolate Mofetil and Its Clinical Application

A Novel Derivative of (-)mycousnine Produced by the Endophytic Fungus Mycosphaerella nawae, Exhibits High and Selective Immunosuppressive Activity on T Cells

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

A Novel Water-Soluble Benzothiazole Derivative BD926 Inhibits Human Activated T Cell Proliferation by Down-Regulating the STAT5 Activation.

Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro

Anisomycin inhibits the behaviors of T cells and the allogeneic skin transplantation in mice.